A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.
4 Bekeken
• 07/10/23
0
0
insluiten
administrator
abonnees
A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties